Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications clinical trials

Explore recruiting multiple sclerosis ms or clinically isolated syndrome cis in line with the locally approved indications clinical trials.

Also recruiting in Europe

Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase IV, Multicenter, Open-Label Study Evaluating B-Cell Levels in Infants Potentially Exposed to Ocrelizumab During Pregnancy – The MINORE Study

Spain, Germany

Therapeutic use (Phase IV) EU CTIS Study details

Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications trials by city

Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications in Toronto Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications in Vancouver Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications in Montreal Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications in Calgary Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications in Edmonton Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications in Ottawa Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications in Winnipeg Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications in Quebec City Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications in Hamilton Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications in Kitchener Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications in London Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications in Halifax Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications in New York Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications in Los Angeles Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications in Chicago Multiple Sclerosis Ms Or Clinically Isolated Syndrome Cis In Line With The Locally Approved Indications in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease